share_log

Wedbush Cuts Beam Therapeutics' Price Target to $100 From $152, Citing Liver Programs Timeline, Lowered Ramp for BEAM-101; Outperform Rating Kept

Wedbush Cuts Beam Therapeutics' Price Target to $100 From $152, Citing Liver Programs Timeline, Lowered Ramp for BEAM-101; Outperform Rating Kept

韦德布什将BEAM Treateutics的目标价从152美元下调至100美元,理由是肝脏计划时间表,下调了BEAM-101的斜率;保持跑赢评级
MT Newswires ·  2022/05/10 04:47

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发